A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
長寿研究の世界で、いま最も注目されているキーワードのひとつが「部分的リプログラミング」だ。今年3月に発表された論文「Cellular reprogramming beyond pluripotency(多能性化を超えた細胞リプログラミング)」は、その ...
Image: CC] On Tuesday, Boston-based biotech startup Life Biosciences announced the dosing of its first patient with a cellular reprogramming injection, designed to reverse age-re ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
'30 years of research came down to one moment.' ...